Cited by 158Sarcoma Diagnosis and TreatmentRadiation Therapy and DosimetryBone Tumor Diagnosis and Treatments

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk

Open access
Matsunobu, Akira, Imai, Reiko, Kamada, Tadashi, Imaizumi, Takeshi, Tsuji, Hiroshi, Tsujii, Hirohiko, Shioyama, Yoshiyuki, Honda, Hiroshi +2 more·2012·Cancer

Abstract

BACKGROUND: The authors summarized the outcomes of patients with unresectable osteosarcoma of the trunk who received carbon ion radiotherapy (CIRT). METHODS: The authors performed a retrospective analysis of 78 patients who had medically inoperable osteosarcoma of the trunk and received treatment with CIRT between 1996 and 2009. Tumor sites included the pelvis in 61 patients, the spine and paraspinal region in 15 patients, and other sites in 2 patients. The median applied CIRT dose was 70.4 Gray equivalent (GyE) in a total of 16 fixed fractions over 4 weeks. RESULTS: The minimum duration of follow‐up for survivors was 14 months. Forty‐eight patients remained alive. The 5‐year overall survival rate was 33%, and the local control rate was 62%. Thirty‐eight patients who had a clinical target volume <500 cm 3 had a 5‐year overall survival rate of 46% and a 5‐year local control rate of 88%. Except for 3 patients who experienced severe skin/soft tissue complications requiring skin grafts, no other severe toxicities were observed. Of 9 patients who were continuously disease free for >5 years, 8 were able to walk with or without the help of a cane, and 6 were free from pain killers. CONCLUSIONS: CIRT appeared to be a safe and effective modality for the management of unresectable osteosarcoma of the trunk, providing good local control and offering a survival advantage and good long‐term functional results without unacceptable morbidity. Cancer 2012. © 2012 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.27451

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Five-year local control rates of 62-67% in patients with inoperable pelvic and trunk sarcomas are encouraging.

    “Five-year local control rates of 62-67% in patients with inoperable pelvic and trunk sarcomas are encouraging 138,139 .”

    From Osteosarcoma (2022) · cites this paper as [139]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis-oncologic results of 40 patients. Clin Orthop. 1998;348: 196-207.

Cited by

Sorted by citations

Authors
Matsunobu, A., Imai, R., Kamada, T., Imaizumi, T., Tsuji, H., Tsujii, H., Shioyama, Y., Honda, H., Tatezaki, S., & for the Working Group for Bone and Soft Tissue Sarcomas
Affiliations
  • Kyushu University (JP)
  • National Institute of Radiological Sciences (JP)
  • Chiba Cancer Center (JP)
Corresponding author
Imai, Reiko
Venue
Cancer
Publisher
Wiley
Published
2012-02-22
Volume
118
Issue
18
Pages
4555-4563
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1600280574
Cited by
158
References
34
Citations by year
2026: 4 · 2025: 9 · 2024: 11 · 2023: 16 · 2022: 14 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 9 · 2012: 3
FWCI
7.21
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • QST-Repository (National Institutes for Quantum and Radiological Science and Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
  • Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
Keywords
carbon ion radiotherapy, osteosarcoma, trunk, unresectable tumors, pelvis, spine, local control, overall survival, clinical target volume, treatment toxicity, functional outcome
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Bone Neoplasms, Child, Female, Humans, Male, Middle Aged, Retrospective Studies, Osteosarcoma, Treatment Outcome, Young Adult, Heavy Ion Radiotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review